- Home
- ELSE vs SABS Comparison
ELSE vs SABS Comparison
Compare ELSE & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELSE
- SABS
- Stock Information
- Founded
- ELSE 1968
- SABS 2014
- Country
- ELSE United States
- SABS United States
- Employees
- ELSE N/A
- SABS N/A
- Industry
- ELSE Industrial Machinery/Components
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- ELSE Industrials
- SABS Health Care
- Exchange
- ELSE Nasdaq
- SABS Nasdaq
- Market Cap
- ELSE 14.7M
- SABS 15.8M
- IPO Year
- ELSE N/A
- SABS N/A
- Fundamental
- Price
- ELSE $4.25
- SABS $1.76
- Analyst Decision
- ELSE
- SABS Strong Buy
- Analyst Count
- ELSE 0
- SABS 5
- Target Price
- ELSE N/A
- SABS $11.80
- AVG Volume (30 Days)
- ELSE 11.2K
- SABS 33.1K
- Earning Date
- ELSE 08-08-2025
- SABS 08-07-2025
- Dividend Yield
- ELSE N/A
- SABS N/A
- EPS Growth
- ELSE 14.32
- SABS N/A
- EPS
- ELSE 0.11
- SABS N/A
- Revenue
- ELSE $9,368,000.00
- SABS $377,835.00
- Revenue This Year
- ELSE N/A
- SABS N/A
- Revenue Next Year
- ELSE N/A
- SABS N/A
- P/E Ratio
- ELSE $39.14
- SABS N/A
- Revenue Growth
- ELSE 7.01
- SABS N/A
- 52 Week Low
- ELSE $3.65
- SABS $1.00
- 52 Week High
- ELSE $5.50
- SABS $5.01
- Technical
- Relative Strength Index (RSI)
- ELSE 52.47
- SABS 47.99
- Support Level
- ELSE $4.15
- SABS $1.60
- Resistance Level
- ELSE $4.40
- SABS $1.80
- Average True Range (ATR)
- ELSE 0.18
- SABS 0.12
- MACD
- ELSE -0.00
- SABS -0.02
- Stochastic Oscillator
- ELSE 55.81
- SABS 50.00
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.